RMD News: With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case - 24th Nov 2022, 11:13pm

annb0t

Top 20
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. But as Peter Lynch said in One Up On Wall Street, 'Long shots almost never pay off.' While a well funded company may sustain losses for years, it will need to generate a profit eventually, or else investors will move on and the company will wither away.

Despite being in the age of tech-stock blue-sky invest...

>>> Read more: With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
 
Top Bottom